Sign in
Taking people in United StatesNo phase

Daily Text Message Symptom Checks for People With Multiple Myeloma or AL Amyloidosis

Looks at daily text message symptom checks in adults treated for these conditions.

Key facts

Who runs it
Mayo Clinic
Where
Rochester, United StatesSee the site
Trial code
Registry title
SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders
Status
Recruiting
People taking part
150 people, planned
Started
25 Aug 2026
Expected to end
25 Aug 2028
Type of study
Observational
Treatments tested
  • Non-Interventional Study
Record updated
30 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with multiple myeloma or AL amyloidosis who are about to start a new treatment. They will get daily text messages about their symptoms.

Age
18 years or older
Sex
All sexes can join
Disease stage
Multiple myeloma (MM) or AL amyloidosis (AL), diagnosed by IMWG diagnostic criteria
Earlier treatment
Planned to start a new treatment within 14 days (+/-7 days)

Main reasons for not taking part

  • Not able to give informed consent

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Age >= 18 years
  • Diagnosis of MM or AL based on IMWG diagnostic criteria
  • Planned to start a new treatment within 14 days (+/-7 days)
  • Able to provide written informed consent

Who cannot take part

  • Not able to give informed consent

Where in United States

  • Mayo Clinic in RochesterRochester, United StatesContact: Sarah AugTaking people

About the trial

What the trial wants to find out

This study evaluates whether daily SMS-based (text messages) symptom monitoring is feasible and acceptable in patients who are undergoing treatment for multiple myeloma (MM) or systemic light chain amyloidosis (AL), and whether it can help in early identification of symptoms that may require clinical attention.

The group in the trial

  • Observational

    Patients are enrolled in the Quality of life text message system and receive SMS text messages and complete questionnaires daily for 3 months on study.

    Treatment: Non-Interventional Study

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders
Plain-language title
Daily Text Message Symptom Checks for People With Multiple Myeloma or AL AmyloidosisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 13 November 2026.
Record updated
30 September 2026